Provided by Tiger Trade Technology Pte. Ltd.

Sensei Biotherapeutics, Inc.

8.86
-0.0400-0.45%
Volume:14.78K
Turnover:131.91K
Market Cap:11.18M
PE:-0.46
High:9.07
Open:8.65
Low:8.65
Close:8.90
52wk High:18.35
52wk Low:5.00
Shares:1.26M
Float Shares:828.30K
Volume Ratio:0.19
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19.1560
EPS(LYR):-24.0130
ROE:-70.18%
ROA:-37.04%
PB:0.49
PE(LYR):-0.37

Loading ...

BRIEF-Egle Therapeutics Appoints John Celebi As Chief Executive Officer

Reuters
·
Jan 07

Sensei Biotherapeutics Sets New Executive Salaries and Retention Bonuses

Reuters
·
Dec 24, 2025

Cambrian BioPharma Inc Reports Disposal of Sensei Biotherapeutics Common Shares

Reuters
·
Dec 11, 2025

James Peyer, 10% Owner, Sells Common Shares of Sensei Biotherapeutics Inc

Reuters
·
Dec 09, 2025

What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump?

Benzinga_recent_news
·
Dec 05, 2025

Sensei Biotherapeutics Inc. Files Initial Statement of Beneficial Ownership for President & PEO Christopher Gerry

Reuters
·
Nov 25, 2025

Sensei Biotherapeutics Reports Strategic Shift in Q3 2025

TIPRANKS
·
Nov 15, 2025

Sensei Biotherapeutics Q3 loss narrows; reduces workforce by 65%

Reuters
·
Nov 14, 2025

Sensei Biotherapeutics Q3 EPS $(3.62) Beats $(4.11) Estimate

Benzinga
·
Nov 14, 2025

Sensei Biotherapeutics reports Q3 EPS ($3.62) vs ($5.77) last year

TIPRANKS
·
Nov 14, 2025

Sensei Biotherapeutics Inc - Reduces Workforce by 65 Percent

THOMSON REUTERS
·
Nov 14, 2025

Press Release: Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Dow Jones
·
Nov 14, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna

Reuters
·
Oct 31, 2025

Sensei Biotherapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Oct 31, 2025

H.C. Wainwright downgrades Sensei on shelving of solnerstotug

TIPRANKS
·
Oct 30, 2025

Sensei Biotherapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
Oct 30, 2025

BUZZ-Sensei falls as it scraps cancer drug development, plans to sell itself

Reuters
·
Oct 30, 2025

Sensei Biotherapeutics Discontinues Solnerstotug Development

TIPRANKS
·
Oct 30, 2025

Sensei Biotherapeutics Inc - Exploring Strategic Alternatives Including Sale, Merger, or Wind-Down

THOMSON REUTERS
·
Oct 30, 2025

Sensei Biotherapeutics Inc: Plans to Retain Small Team of Employees to Assist in Exploring Strategic Alternatives

THOMSON REUTERS
·
Oct 30, 2025